IFNA1 and hepatocellular carcinoma: In this study, we applied the methods of oligonucleotide microarray system and gene network analysis to identify informative gene set(s) and signalling pathway(s) related to resistance to IFN-α/5-FU combination therapy, especially in patients with IFNAR2-positive HCC.